Clinical Trial Update: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating potential disease-modifying treatments for early-onset Alzheimer's disease caused by a genetic mutation, enrolling indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Alzheimer Disease Familial
• Dementia

Snippet

Sponsor: Washington University School of Medicine | Conditions: Alzheimers Disease, Dementia | Phase 2, Phase 3 | Status: RECRUITING